PRESS RELEASE
2 November 2021

Pending Patent & Pharma Legislation Roundup - Thursday, November 18, 2021

AB
Alston & Bird

Contributor

Pending legislation may significantly affect various aspects of patent litigation, especially in the pharmaceutical industry.
United States

THURSDAY, NOVEMBER 18, 2021
4:00 PM ET / 1:00 PM PT

Pending legislation may significantly affect various aspects of patent litigation, especially in the pharmaceutical industry. Join partners Shri Abhyankar, Christopher McArdle, and senior associate Emily Shaw as they provide an overview of the pending legislation and its potential impact. We will also discuss the "Restoring the America Invents Act," the "Pride in Patent Ownership Act," and several important bills impacting generic pharmaceutical litigation.

Speakers:

  • Shri Abhyankar
    Partner, Intellectual Property Litigation
    Alston & Bird 
    Atlanta
  • Christopher McArdle
    Partner, Intellectual Property Litigation
    Alston & Bird 
    New York
  • Emily Shaw
    Senior Associate, Health Care
    Alston & Bird 
    Washington D.C.

REGISTER HERE

Contributor

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More